Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device DesignationNEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the PoNS (Portable Neuromodulation Stimulator) device label expansion seeking an indication for gait and balance deficit in patients with chronic stroke symptoms. The submission was ...

Not only have these stocks raised their dividends consistently, but they also offer above-average yields.Stocks that pay dividends can make for great long-term investments. The best reason to invest in them is that they can generate recurring cash flow for you on an ongoing basis.What's even better are dividend stocks that raise their payments over time. That's crucial because inflation can chip away at dividend income. Let's assume you collect $1,000 in dividends per year. Assuming the inflation rate avera ...

A Fanuc robotic arm moves bins of products during a media tour of the Amazon.com Inc. DAB2 fulfillment center in Daytona Beach, Florida, US, on Tuesday, Sept. 23, 2025. The DAB2 fulfillment center is Amazon's seventh robotics fulfillment center in Florida. Photographer: Miguel J. Rodriguez Carrillo/Bloomberg via Getty ImagesThe Trump administration has launched national security investigations into imports of robotics, industrial machinery and medical devices, a move that could pave the way for fresh tariff ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW). If you currently own shares of Edwards stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=29704 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com. Why Rosen La. ...

Independent DSMB reports zero device-related safety issuesSupports potential clinical benefitTrial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that the independent Data Safety Monitoring Review Board (DSMB) has recommended the continuation ...

PHILADELPHIA, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of STAAR Surgical Company (NASDAQ: STAA) (“STAAR” or the “Company”) shareholders to determine whether the proposal is fair to investors.  Click here for additional information: https://kaskelalaw.com/case/staar-surgical/  On August 5, 2025, STAAR announced that it had agreed to be acquired by Alcon at a price of $28.00 per share in cash. F ...

Question-and-Answer SessionGood. So you've been on the job kind of about 6 months now. So maybe if you think about the first 6 months and coming into Medtronic, curious how you're thinking about the business today and how you want investors to kind of think about your plan for kind of shareholder value creation from here and sort of the initial earnings here in the first 6 months?Thierry PietonExecutive VP & CFO Yes. So look, one of the reasons or some of the reasons I decided to join Medtronic is, first, I ...

Abbott Laboratories (NYSE:ABT) is included among the Best Retirement Stocks for a Dividend Stock Portfolio. Building Consistent Income in a Dividend Stock Portfolio with Abbott Laboratories (ABT) Photo by Dan Dennis on Unsplash Abbott Laboratories (NYSE:ABT) operates a broad business spanning four main areas: medical devices, established pharmaceuticals, diagnostics, and nutrition. With a strong global presence, its diversified structure helps balance performance when one segment experiences weakness. ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether DexCom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 18, 2025 ...

Key Takeaways HOLX will discontinue Fluoroscan InSight FD by Sept. 30, 2025 due to low margins and limited growth.Hologic's Skeletal Health sales rose 62.1% in Q3 on Horizon DXA ramp-up, boosting overall performance.HOLX narrowed the 2025 revenue guidance to $4.081-$4.091B after strong results and easing tariffs.Hologic’s (HOLX) Skeletal Health division has been driving positive contributions ever since the earlier supply challenges began to ease. Sales jumped 62.1% in the third quarter of fiscal 2025, driv ...